Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

The major secreted protein of the whipworm parasite tethers to matrix and inhibits interleukin-13 function.

Tytuł:
The major secreted protein of the whipworm parasite tethers to matrix and inhibits interleukin-13 function.
Autorzy:
Bancroft AJ; Lydia Becker Institute for Immunology and Inflammation, Manchester, M13 9PT, UK. .; Wellcome Trust Centre for Cell Matrix Research, Manchester, M13 9PT, UK. .; Division of Infection, Immunity and Respiratory Medicine, Manchester, M13 9PT, UK. .; School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, M13 9PL, UK. .
Levy CW; Manchester Institute of Biotechnology, University of Manchester, 3.020 Garside Building, 131 Princess Street, Manchester, M1 7DN, UK.
Jowitt TA; Wellcome Trust Centre for Cell Matrix Research, Manchester, M13 9PT, UK.; School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, M13 9PL, UK.
Hayes KS; Lydia Becker Institute for Immunology and Inflammation, Manchester, M13 9PT, UK.; Wellcome Trust Centre for Cell Matrix Research, Manchester, M13 9PT, UK.; Division of Infection, Immunity and Respiratory Medicine, Manchester, M13 9PT, UK.; School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, M13 9PL, UK.
Thompson S; Lydia Becker Institute for Immunology and Inflammation, Manchester, M13 9PT, UK.; Wellcome Trust Centre for Cell Matrix Research, Manchester, M13 9PT, UK.; Division of Infection, Immunity and Respiratory Medicine, Manchester, M13 9PT, UK.; School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, M13 9PL, UK.
Mckenzie EA; Manchester Institute of Biotechnology, University of Manchester, 3.020 Garside Building, 131 Princess Street, Manchester, M1 7DN, UK.
Ball MD; Manchester Institute of Biotechnology, University of Manchester, 3.020 Garside Building, 131 Princess Street, Manchester, M1 7DN, UK.
Dubaissi E; Lydia Becker Institute for Immunology and Inflammation, Manchester, M13 9PT, UK.; Wellcome Trust Centre for Cell Matrix Research, Manchester, M13 9PT, UK.; Division of Infection, Immunity and Respiratory Medicine, Manchester, M13 9PT, UK.; School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, M13 9PL, UK.
France AP; Manchester Institute of Biotechnology, University of Manchester, 3.020 Garside Building, 131 Princess Street, Manchester, M1 7DN, UK.
Bellina B; Manchester Institute of Biotechnology, University of Manchester, 3.020 Garside Building, 131 Princess Street, Manchester, M1 7DN, UK.
Sharpe C; Lydia Becker Institute for Immunology and Inflammation, Manchester, M13 9PT, UK.; Wellcome Trust Centre for Cell Matrix Research, Manchester, M13 9PT, UK.; Division of Infection, Immunity and Respiratory Medicine, Manchester, M13 9PT, UK.; School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, M13 9PL, UK.
Mironov A; School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, M13 9PL, UK.
Brown SL; Lydia Becker Institute for Immunology and Inflammation, Manchester, M13 9PT, UK.; Division of Infection, Immunity and Respiratory Medicine, Manchester, M13 9PT, UK.; School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, M13 9PL, UK.; Manchester Collaborative Centre for Inflammation Research, Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, Core Technology, University of Manchester, 46 Grafton Street, Manchester, M13 9NT, UK.
Cook PC; Lydia Becker Institute for Immunology and Inflammation, Manchester, M13 9PT, UK.; Division of Infection, Immunity and Respiratory Medicine, Manchester, M13 9PT, UK.; School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, M13 9PL, UK.; Manchester Collaborative Centre for Inflammation Research, Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, Core Technology, University of Manchester, 46 Grafton Street, Manchester, M13 9NT, UK.
S MacDonald A; Lydia Becker Institute for Immunology and Inflammation, Manchester, M13 9PT, UK.; Division of Infection, Immunity and Respiratory Medicine, Manchester, M13 9PT, UK.; School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, M13 9PL, UK.; Manchester Collaborative Centre for Inflammation Research, Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, Core Technology, University of Manchester, 46 Grafton Street, Manchester, M13 9NT, UK.
Thornton DJ; Lydia Becker Institute for Immunology and Inflammation, Manchester, M13 9PT, UK.; Wellcome Trust Centre for Cell Matrix Research, Manchester, M13 9PT, UK.; Division of Infection, Immunity and Respiratory Medicine, Manchester, M13 9PT, UK.; School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, M13 9PL, UK.
Grencis RK; Lydia Becker Institute for Immunology and Inflammation, Manchester, M13 9PT, UK. .; Wellcome Trust Centre for Cell Matrix Research, Manchester, M13 9PT, UK. .; Division of Infection, Immunity and Respiratory Medicine, Manchester, M13 9PT, UK. .; School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, M13 9PL, UK. .
Źródło:
Nature communications [Nat Commun] 2019 May 28; Vol. 10 (1), pp. 2344. Date of Electronic Publication: 2019 May 28.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
Język:
English
Imprint Name(s):
Original Publication: [London] : Nature Pub. Group
MeSH Terms:
Helminth Proteins/*metabolism
Interleukin-13/*metabolism
Intestinal Diseases, Parasitic/*metabolism
Proteoglycans/*metabolism
Trichuris/*metabolism
Animals ; Extracellular Matrix/metabolism ; Helminth Proteins/immunology ; Interleukin-13/immunology ; Interleukin-13 Receptor alpha2 Subunit/metabolism ; Intestinal Diseases, Parasitic/immunology ; Mice ; Sequence Homology, Amino Acid ; Thrombospondin 1/metabolism ; Trichuriasis
References:
Adv Parasitol. 2010;73:197-230. (PMID: 20627144)
J Extracell Vesicles. 2018 Jan 21;7(1):1428004. (PMID: 29410780)
Immunity. 2017 Oct 17;47(4):739-751.e5. (PMID: 29045903)
J Biol Chem. 2008 Oct 3;283(40):27017-27. (PMID: 18669635)
J Biol Chem. 2007 Jul 20;282(29):21032-42. (PMID: 17517889)
J Immunol. 2004 Jun 15;172(12):7635-41. (PMID: 15187144)
IUCrJ. 2014 May 30;1(Pt 4):213-20. (PMID: 25075342)
Anal Chem. 2015 Apr 21;87(8):4370-6. (PMID: 25799115)
Glycobiology. 2007 Aug;17(8):868-76. (PMID: 17494086)
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501. (PMID: 20383002)
Nat Protoc. 2014 Jan;9(1):209-22. (PMID: 24385150)
Immunol Rev. 2004 Dec;202:191-202. (PMID: 15546394)
Sci Transl Med. 2016 Oct 26;8(362):362ra143. (PMID: 27797959)
Immunol Rev. 2004 Oct;201:139-55. (PMID: 15361238)
Nat Commun. 2017 Nov 23;8(1):1741. (PMID: 29170498)
J Immunol. 2017 Feb 15;198(4):1627-1637. (PMID: 28069805)
Int J Parasitol. 2017 Aug;47(9):529-544. (PMID: 28336271)
J Immunol. 2001 Aug 15;167(4):1982-8. (PMID: 11489979)
Proc Natl Acad Sci U S A. 2014 Apr 1;111(13):4862-7. (PMID: 24639528)
Nucleic Acids Res. 2016 Jul 8;44(W1):W351-5. (PMID: 27131377)
Methods Mol Biol. 2018;1757:471-491. (PMID: 29761467)
Parasitology. 1967 Aug;57(3):515-24. (PMID: 6048569)
Bull World Health Organ. 2003;81(5):343-52. (PMID: 12856052)
PLoS One. 2010 Oct 13;5(10):e13343. (PMID: 20967224)
Nat Genet. 2014 Jul;46(7):701-6. (PMID: 24929829)
J Mol Biol. 2007 Sep 21;372(3):774-97. (PMID: 17681537)
Adv Parasitol. 2004;57:255-307. (PMID: 15504540)
Nat Commun. 2015 Apr 24;6:6920. (PMID: 25908537)
Methods Mol Biol. 2012;917:431-44. (PMID: 22956102)
J Chem Inf Model. 2012 Feb 27;52(2):604-12. (PMID: 22268964)
Acta Crystallogr D Biol Crystallogr. 2012 Apr;68(Pt 4):352-67. (PMID: 22505256)
J Immunol. 1998 Apr 1;160(7):3453-61. (PMID: 9531306)
Nat Immunol. 2019 May;20(5):571-580. (PMID: 30936493)
Lancet. 2018 Jan 20;391(10117):252-265. (PMID: 28882382)
Nat Genet. 2014 Jul;46(7):693-700. (PMID: 24929830)
Immunol Rev. 2004 Oct;201:75-88. (PMID: 15361234)
Protein Sci. 2010 Oct;19(10):1985-90. (PMID: 20684023)
Acta Crystallogr D Biol Crystallogr. 2007 Apr;63(Pt 4):550-4. (PMID: 17372361)
Grant Information:
United Kingdom Wellcome Trust; WT100290MA International Wellcome Trust (Wellcome); Z10661/Z/18/Z International Wellcome Trust (Wellcome); Z03128/Z/16/Z. International Wellcome Trust (Wellcome)
Substance Nomenclature:
0 (Helminth Proteins)
0 (Interleukin-13)
0 (Interleukin-13 Receptor alpha2 Subunit)
0 (Proteoglycans)
0 (Thrombospondin 1)
Entry Date(s):
Date Created: 20190530 Date Completed: 20190617 Latest Revision: 20210109
Update Code:
20240104
PubMed Central ID:
PMC6538607
DOI:
10.1038/s41467-019-09996-z
PMID:
31138806
Czasopismo naukowe
Infection by soil transmitted parasitic helminths, such as Trichuris spp, are ubiquitous in humans and animals but the mechanisms determining persistence of chronic infections are poorly understood. Here we show that p43, the single most abundant protein in T. muris excretions/secretions, is non-immunogenic during infection and has an unusual sequence and structure containing subdomain homology to thrombospondin type 1 and interleukin (IL)-13 receptor (R) α2. Binding of p43 to IL-13, the key effector cytokine responsible for T. muris expulsion, inhibits IL-13 function both in vitro and in vivo. Tethering of p43 to matrix proteoglycans presents a bound source of p43 to facilitate interaction with IL-13, which may underpin chronic intestinal infection. Our results suggest that exploiting the biology of p43 may open up new approaches to modulating IL-13 function and control of Trichuris infections.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies